We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+13.24%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.44B
AUM Growth
-$133M
(-5.2%)
Cap. Flow
-$77.2M
Cap. Flow
% of AUM
-3.16%
Top 10 Holdings %
Top 10 Hldgs %
50.14%
Holding
73
New
3
Increased
9
Reduced
33
Closed
4
Top Buys
| 1 |
AKRO
Akero Therapeutics
AKRO
|
+$44.6M |
| 2 |
Prime Medicine
PRME
|
+$39.9M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$34.8M |
| 4 |
Replimune Group
REPL
|
+$24.7M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$23.5M |
Top Sells
| 1 |
argenx
ARGX
|
+$49.2M |
| 2 |
Prothena Corp
PRTA
|
+$31.9M |
| 3 |
ONEM
1Life Healthcare
ONEM
|
+$29.7M |
| 4 |
SkinHealth Systems
SKIN
|
+$24.9M |
| 5 |
LivaNova
LIVN
|
+$22M |
Sector Composition
| 1 | Healthcare | 98.91% |
| 2 | Industrials | 0.92% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
1
DELISTED
Amicus Therapeutics
FOLD
| $247M | 10.11% |
20,249,789
-1,469,402
| -7% | -$16.5M |
|
2
Krystal Biotech
KRYS
$10.2B
| $150M | 6.15% |
1,896,645
-2,900
| -0.2% | -$215K |
|
|
AKRO
3
DELISTED
Akero Therapeutics
AKRO
| $144M | 5.9% |
2,632,912
+1,041,827
| +65% | +$44.6M |
|
|
4
Replimune Group
REPL
$826M
| $131M | 5.38% |
4,831,709
+1,186,400
| +33% | +$24.7M |
|
5
Fate Therapeutics
FATE
$336M
| $131M | 5.35% |
12,957,222
| – | – |
|
|
ISEE
6
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $96.4M | 3.94% |
4,502,111
+1,102,211
| +32% | +$23.5M |
|
7
Xenon Pharmaceuticals
XENE
$6.53B
| $93.1M | 3.81% |
2,360,414
-10,200
| -0.4% | -$371K |
|
8
Celldex Therapeutics
CLDX
$3.01B
| $88.1M | 3.61% |
1,977,451
-7,700
| -0.4% | -$275K |
|
9
Pliant Therapeutics
PLRX
$68.7M
| $75M | 3.07% |
3,878,599
-629,605
| -14% | -$13.2M |
|
10
Beam Therapeutics
BEAM
$3.13B
| $69.2M | 2.83% |
1,770,587
-2,400
| -0.1% | -$107K |
|
11
Kymera Therapeutics
KYMR
$9.3B
| $66.7M | 2.73% |
2,673,837
-202,800
| -7% | -$5.41M |
|
|
12
LivaNova
LIVN
$4.4B
| $61.4M | 2.51% |
1,106,409
-429,953
| -28% | -$22M |
|
|
DCPH
13
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $58.9M | 2.41% |
3,593,317
+620,288
| +21% | +$10.1M |
|
|
IGMS
14
DELISTED
IGM Biosciences
IGMS
| $56.7M | 2.32% |
3,334,355
| – | – |
|
|
15
argenx
ARGX
$54.1B
| $56.3M | 2.3% |
148,517
-131,509
| -47% | -$49.2M |
|
|
16
Jazz Pharmaceuticals
JAZZ
$15.1B
| $50.8M | 2.08% |
318,945
+237,481
| +292% | +$34.8M |
|
17
Penumbra
PEN
$12.5B
| $49.3M | 2.02% |
221,809
+43,017
| +24% | +$8.41M |
|
18
Zymeworks
ZYME
$1.82B
| $48.5M | 1.99% |
6,175,918
+410,100
| +7% | +$2.88M |
|
19
Regenxbio
RGNX
$622M
| $43.4M | 1.78% |
1,913,512
-3,700
| -0.2% | -$83.6K |
|
|
IMGN
20
DELISTED
Immunogen Inc
IMGN
| $42.3M | 1.73% |
8,532,817
-15,328
| -0.2% | -$83.1K |
|
|
21
Prime Medicine
PRME
$616M
| $41M | 1.68% |
+2,209,350
| New | +$39.9M |
|
|
RPTX
22
DELISTED
Repare Therapeutics
RPTX
| $39.5M | 1.62% |
2,684,396
| – | – |
|
|
ONEM
23
DELISTED
1Life Healthcare
ONEM
| $38.9M | 1.59% |
2,326,625
-1,761,000
| -43% | -$29.7M |
|
24
Nurix Therapeutics
NRIX
$2.45B
| $32.9M | 1.35% |
3,000,784
-5,900
| -0.2% | -$71.2K |
|
|
OSH
25
DELISTED
Oak Street Health, Inc.
OSH
| $30.6M | 1.25% |
1,420,617
+359,322
| +34% | +$7.52M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO